Yves Falanga joined EcoR1 Capital as an Entrepreneur-In-Residence in August of 2020 after spending years leading discovery immunology projects in biotech and academia. In addition to driving efforts in venture creation, he is responsible for due diligence and analysis of biotechnology companies for value-oriented investment opportunities. Prior to EcoR1, he was a Senior Scientist in Immunology at Repertoire Immune Medicine. Yves has a Ph.D. in Immunology and Integrative Life Sciences from Virginia Commonwealth University (VCU) and completed his postdoctoral training at the University of Massachusetts Medical School. His work focused on elucidating the functions of Fyn and Lyn kinases in IgG-mediated allergic response and anaphylaxis, as well as characterizing T cells in pediatric infectious diseases and oncology. Yves has a bachelor's degree in biological sciences from Université de Rennes 1 (France) and grew up in the Democratic Republic of the Congo.